Month: January 2021
-
US Govt to Buy 1.25M Regeneron Covid-19 Therapies
The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion.
-
Drug Maker Gains Access to Hidden Protein Immunotherapies
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Drug Price Disruptor Biotech Raises $500M in New Funds
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round.
-
Infographic – Countries Making Covid-19 Vaccines
The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges.
-
Digital Therapeutics Designed for Cancer/Covid-19 Stress
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
CureVac, Bayer Partner on Covid-19 Vaccine Supply
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine.
-
Protection from Legal Issues With These Core Hacks
These days more and more legal issues present themselves, and that’s why it is important to make sure you protect yourself.
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.